🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementHypoglycemia risk with concomitant sulfonylurea use — my results so far Page 4

Hypoglycemia risk with concomitant sulfonylurea use — my results so far

mike.trainer_LA Mon, Jan 8, 2024 at 5:38 PM 34 replies 2,155 viewsPage 4 of 7
mike.trainer_LA
Senior Member
1,567
7,234
Apr 2024
Los Angeles, CA
Jan 8, 2024 at 11:18 PM#16

OP here — wow, did not expect this much response! Thank you all for the thoughtful replies on Hypoglycemia risk with.

To answer stefan_berlin: my doctor and I discussed the options and went with brand.

Quick update: I have noticed more improvement since posting this. Thanks again for the evidence-based discussion — this is exactly why I posted in a science-based community. 🙏

7 10Dr.AddMedPHL, newstart_MO, mia_MS2 and 4 others
Reply Quote Save Share Report
Dr.NateNeph
VIP Member
2,987
16,234
Dec 2023
Houston, TX
Jan 8, 2024 at 11:35 PM#17

Adding my data to this Hypoglycemia risk with discussion:

MetricBaselineMonth 3Month 6
Weight272 lbs242 lbs207 lbs
A1C6.6%5.8%5.2%
hsCRP6.02.00.6

Protocol: Semaglutide 2.4mg/wk, resistance training 3x/wk, protein 1.4g/kg/day.

21 1NauseaFreeNow, SteveThurs, B12Beth and 18 others
Reply Quote Save Share Report
james_edin
Member
289
1,234
Sep 2024
Edinburgh, UK
Jan 8, 2024 at 11:52 PM#18

Exactly this. My pharmacist said the same thing about Hypoglycemia risk.

Last edited: Jan 9, 2024 at 1:52 AM
23 11tane_welly, Dr.PathRoch, mona_PHX and 20 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
BethLabQueen
Senior Member
1,234
5,678
May 2024
Virginia
Online
Jan 9, 2024 at 12:09 AM#19

Slightly tangential to Hypoglycemia risk with but FranDenver reminded me — what is the latest on the oral formulations?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

6 6cory_ATX, lori_vegas, Dr.PulmRoch and 3 others
Reply Quote Save Share Report
ingrid_STO
Member
345
1,456
Jul 2024
Stockholm, SE
Jan 9, 2024 at 12:26 AM#20

+1 to mike.trainer_LA. Especially the point about "Thank you all for the thoughtful replies..." — I have seen the same in my own experience with Hypoglycemia risk with.

24 4WendyG_ATL, SaraMom3, Dr.MetabolicMD and 21 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register